$2.33T
Total marketcap
$78.51B
Total volume
BTC 50.01%     ETH 15.35%
Dominance

Bionoid Pharma BINP Stock

0.25 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
13.5M USD
LOW - HIGH [24H]
0.25 - 0.25 USD
VOLUME [24H]
300 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.3 USD

Bionoid Pharma Price Chart

Bionoid Pharma BINP Financial and Trading Overview

Bionoid Pharma stock price 0.25 USD
Previous Close 0.45 USD
Open 0.15 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.45 - 0.45 USD
52 Week Range 0.04 - 2.3 USD
Volume 6 USD
Avg. Volume 120 USD
Market Cap 19.03M USD
Beta (5Y Monthly) -2.510211
PE Ratio (TTM) N/A
EPS (TTM) -1.3 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BINP Valuation Measures

Enterprise Value 81.57K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 206.22115
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.884
Enterprise Value/EBITDA -0.211

Trading Information

Bionoid Pharma Stock Price History

Beta (5Y Monthly) -2.510211
52-Week Change -39.99%
S&P500 52-Week Change 20.43%
52 Week High 2.3 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.24 USD
200-Day Moving Average 0.84 USD

BINP Share Statistics

Avg. Volume (3 month) 120 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 42.28M
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:2500

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2013
Most Recent Quarter (mrq) March 31, 2012
Next Fiscal Year End December 31, 2014

Profitability

Profit Margin 0%
Operating Margin (ttm) -421.66%
Gross Margin 51.46%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -164.12%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 92.26K USD
Revenue Per Share (ttm) 2.63 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 47.48K USD
EBITDA -385710 USD
Net Income Avi to Common (ttm) -1622945 USD
Diluted EPS (ttm) -2.34
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 127 USD
Total Cash Per Share (mrq) 0.003 USD
Total Debt (mrq) 64.5K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.073
Book Value Per Share (mrq) -29.919

Cash Flow Statement

Operating Cash Flow (ttm) -357621 USD
Levered Free Cash Flow (ttm) -440920 USD

Profile of Bionoid Pharma

Country United States
State CA
City Beverly Hills
Address 433 North Camden
ZIP 90210
Phone 800 784 7641
Website https://bionoidpharma.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 5

Bionoid Pharma Inc. engages in the hemp cultivation business. The company is based in Beverly Hills, California.

Q&A For Bionoid Pharma Stock

What is a current BINP stock price?

Bionoid Pharma BINP stock price today per share is 0.25 USD.

How to purchase Bionoid Pharma stock?

You can buy BINP shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bionoid Pharma?

The stock symbol or ticker of Bionoid Pharma is BINP.

Which industry does the Bionoid Pharma company belong to?

The Bionoid Pharma industry is Drug Manufacturers-Specialty & Generic.

How many shares does Bionoid Pharma have in circulation?

The max supply of Bionoid Pharma shares is 53.99M.

What is Bionoid Pharma Price to Earnings Ratio (PE Ratio)?

Bionoid Pharma PE Ratio is now.

What was Bionoid Pharma earnings per share over the trailing 12 months (TTM)?

Bionoid Pharma EPS is -1.3 USD over the trailing 12 months.

Which sector does the Bionoid Pharma company belong to?

The Bionoid Pharma sector is Healthcare.